Company Name:CRISPR Therapeutics AG
CEO:

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics.


Key numbers

Market Capitalization:3139451480
Shares Outstanding: 55204000
Float: 30002325.123999998
Next Earning Date:2020-03-06
TTm EPS: -0.3349
TTm Dividend Rate:
200 days moving average:42.25
50 days moving average: 44.75
One day percent Change: 42.71



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,